Inventor
GRANT MARSHALL L
US19 patents
⚠️ This page may combine multiple inventors who share the name “GRANT MARSHALL L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MANNKIND CORP
16 patentsUS8778403B2Jul 15, 2014
Diketopiperazine microparticles with defined specific surface areas
MANNKIND CORP48 citations97
US9925144B2Mar 27, 2018
Heat-stable dry powder pharmaceutical compositions and methods
MANNKIND CORP13 citations90
US10772883B2Sep 15, 2020
Diketopiperazine microparticles with defined specific surface areas
MANNKIND CORP6 citations83
US9630930B2Apr 25, 2017
Diketopiperazine microparticles with defined specific surface areas
MANNKIND CORP4 citations83
US11013691B2May 25, 2021
Heat-stable dry powder pharmaceutical compositions and methods
MANNKIND CORP6 citations81
US10413513B2Sep 17, 2019
Heat-stable dry powder pharmaceutical compositions and methods
MANNKIND CORP5 citations81
US10421729B2Sep 24, 2019
Microcrystalline diketopiperazine compositions and methods
MANNKIND CORP3 citations72
US9283193B2Mar 15, 2016
Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
MANNKIND CORP2 citations72
US11013692B2May 25, 2021
Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
MANNKIND CORP0 citations71
US10357459B2Jul 23, 2019
Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
MANNKIND CORP1 citations71
US10159644B2Dec 25, 2018
Inhalable vaccine compositions and methods
MANNKIND CORP5 citations70
US12383552B2Aug 12, 2025
Diketopiperazine microparticles with defined specific surface areas
MANNKIND CORP0 citations62
US11607410B2Mar 21, 2023
Diketopiperazine microparticles with defined specific surface areas
MANNKIND CORP0 citations62
US11192862B2Dec 7, 2021
Microcrystalline diketopiperazine compositions and methods
MANNKIND CORP0 citations62
US9717689B2Aug 1, 2017
Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
MANNKIND CORP0 citations61
US10745359B2Aug 18, 2020
Microcrystalline diketopiperazine compositions and methods
MANNKIND CORP0 citations51